ALENTIS
Live / Registered — Registered (as of 10 Sept 2024)
What this means for you
Registered since 10 Sept 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98196287
- Registration number
- 7500787
- Mark type
- Design + words
- Filed
- 25 Sept 2023
- Published for opposition
- 25 Jun 2024
- Registered
- 10 Sept 2024
- Attorney of record
- Dermot Horgan
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products, for the treatment of cancer, autoimmune diseases, and organ fibrosis; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, autoimmune diseases, and organ fibrosis; biological preparations for medical and therapeutic use for the treatment of cancer, autoimmune diseases, and organ fibrosis; all the aforesaid goods not for ophthalmological use; biopharmaceutical products, namely, pharmaceutical preparations for cancer treatment; pharmaceutical preparations and substances for cancer treatment; pharmaceutical preparations and substances for cancer prevention
Owner
- Alentis Therapeutics AG, Allschwil, CH
- Alentis Therapeutics AG, Allschwil, CH
- Alentis Therapeutics AG, Allschwil, CH
Prior registrations
Prosecution history
- 10 Sept 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Sept 2024 — REGISTERED-PRINCIPAL REGISTER
- 25 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jun 2024 — PUBLISHED FOR OPPOSITION
- 05 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 May 2024 — ASSIGNED TO EXAMINER
- 22 Feb 2024 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 22 Feb 2024 — ASSIGNED TO LIE
- 01 Oct 2023 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 11 Oct 2023 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 10 Oct 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Sept 2023 — NEW APPLICATION ENTERED